The University of Nebraska Medical Center through the Division of Addiction Medicine in the Department of Psychiatry is offering a one month educational experience in addiction medicine to interested medical professionals both in and out of graduate training. This rotation will allow for an initial immersive experience into the assessment, diagnosis and treatment of patients with substance use disorders and unhealthy substance use. Through a combination of clinical experiences involving inpatient and outpatient treatment, the rotation will offer the ability to gain skills to learn to evaluate and manage patients with addictive disorders. A series of live and web based didactics guided by faculty members will help the executive fellow gain insight into the neurobiology, epidemiology, and pharmacologic and psychosocial treatment of addiction. One of the goals is to gain the education necessary to be able to prescribe buprenorphine-naloxone for the treatment of opioid use disorder and to see how that treatment works in a clinical setting. The fellowship will require 25-30 hours per week for the 4 week block.
The following are the initial educational objectives:
- Understand what is involved with the comprehensive assessment, diagnosis, and treatment of patients with substance-related health problems and substance use disorders along the available continuum of care to include inpatient and outpatient treatment options.
- Demonstrate knowledge of the medical model of addiction including the pharmacology of common psychoactive substances, including alcohol, nicotine, stimulants, sedative-hypnotics, opioids, inhalants, hallucinogens, and cannabinoids.
- Understand common co-occurring conditions, both medical and psychiatric, that are present with patients with substance use disorders.
- Become aware of the pharmacotherapy and psychosocial interventions for substance use disorders across the age spectrum.
- Attain the training necessary to apply for a waiver to prescribe buprenorphine for the treatment of opioid use disorder.
The inpatient clinical sites include the addiction Consult/Liaison service at Nebraska Medicine and the inpatient residential treatment center at the VA. The outpatient experience will include outpatient co-occurring addiction clinic, outpatient adolescent recovery clinic, intensive outpatient for patients with co-occurring disorders, and the Bay Mark/BAART opioid treatment program. The fellows will also spend time with the social work therapists to become familiar with psychotherapeutic interventions.